 Molishree Joshi
Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carnitine O-Palmitoyltransferase | 2 | 2020 | 47 | 1.370 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2019 | 41 | 0.670 |
Why?
| | Androgen Antagonists | 1 | 2019 | 70 | 0.660 |
Why?
| | Androgens | 1 | 2019 | 167 | 0.620 |
Why?
| | Lipid Metabolism | 1 | 2020 | 467 | 0.570 |
Why?
| | Cell Proliferation | 3 | 2020 | 2236 | 0.530 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2019 | 669 | 0.500 |
Why?
| | Head and Neck Neoplasms | 3 | 2023 | 478 | 0.450 |
Why?
| | Gene Dosage | 1 | 2008 | 135 | 0.310 |
Why?
| | Transgenes | 1 | 2008 | 173 | 0.300 |
Why?
| | Green Fluorescent Proteins | 1 | 2008 | 390 | 0.280 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1001 | 0.260 |
Why?
| | Endothelial Cells | 1 | 2008 | 698 | 0.220 |
Why?
| | Sentinel Lymph Node | 1 | 2022 | 40 | 0.210 |
Why?
| | Receptor, EphB4 | 1 | 2022 | 29 | 0.210 |
Why?
| | Ephrin-B2 | 1 | 2022 | 42 | 0.210 |
Why?
| | B7-H1 Antigen | 1 | 2023 | 143 | 0.200 |
Why?
| | Group II Phospholipases A2 | 1 | 2020 | 16 | 0.180 |
Why?
| | Phenylthiohydantoin | 1 | 2019 | 40 | 0.170 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2023 | 450 | 0.170 |
Why?
| | Histone Acetyltransferases | 1 | 2019 | 53 | 0.160 |
Why?
| | Acetylation | 1 | 2019 | 213 | 0.160 |
Why?
| | Nitriles | 1 | 2019 | 154 | 0.160 |
Why?
| | Benzamides | 1 | 2019 | 173 | 0.160 |
Why?
| | Down-Regulation | 1 | 2020 | 606 | 0.150 |
Why?
| | Neoplasms | 2 | 2023 | 2147 | 0.150 |
Why?
| | Down Syndrome | 1 | 2022 | 341 | 0.150 |
Why?
| | Protein Processing, Post-Translational | 1 | 2019 | 408 | 0.140 |
Why?
| | Molecular Targeted Therapy | 1 | 2020 | 354 | 0.140 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 910 | 0.140 |
Why?
| | Esophageal Neoplasms | 1 | 2020 | 276 | 0.140 |
Why?
| | Enzyme Inhibitors | 1 | 2020 | 775 | 0.140 |
Why?
| | Tumor Suppressor Proteins | 1 | 2018 | 286 | 0.140 |
Why?
| | Cell Line, Tumor | 2 | 2019 | 2814 | 0.130 |
Why?
| | Transcription Factors | 2 | 2023 | 1557 | 0.120 |
Why?
| | Histones | 1 | 2019 | 544 | 0.120 |
Why?
| | Adenocarcinoma | 1 | 2020 | 794 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1159 | 0.110 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 610 | 0.110 |
Why?
| | Mice | 5 | 2023 | 15311 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2408 | 0.090 |
Why?
| | Taq Polymerase | 1 | 2008 | 10 | 0.080 |
Why?
| | Carcinoma, Lewis Lung | 1 | 2008 | 13 | 0.080 |
Why?
| | DNA, Neoplasm | 1 | 2008 | 151 | 0.080 |
Why?
| | Adoptive Transfer | 1 | 2008 | 203 | 0.080 |
Why?
| | Plasmids | 1 | 2008 | 352 | 0.070 |
Why?
| | Microscopy, Confocal | 1 | 2008 | 308 | 0.070 |
Why?
| | Humans | 8 | 2023 | 117083 | 0.070 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 860 | 0.070 |
Why?
| | Signal Transduction | 1 | 2019 | 4606 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2008 | 730 | 0.070 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2222 | 0.070 |
Why?
| | Animals | 5 | 2023 | 32741 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2008 | 523 | 0.060 |
Why?
| | Mice, Transgenic | 1 | 2008 | 1993 | 0.060 |
Why?
| | Gene Silencing | 1 | 2023 | 176 | 0.050 |
Why?
| | Centrosome | 1 | 2022 | 59 | 0.050 |
Why?
| | Centrioles | 1 | 2022 | 35 | 0.050 |
Why?
| | Mice, Inbred NOD | 1 | 2023 | 567 | 0.050 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 195 | 0.050 |
Why?
| | Lymph Node Excision | 1 | 2022 | 146 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 145 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2008 | 2831 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2023 | 340 | 0.050 |
Why?
| | Cilia | 1 | 2022 | 161 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2022 | 224 | 0.050 |
Why?
| | Tissue Banks | 1 | 2020 | 18 | 0.050 |
Why?
| | Esophageal Mucosa | 1 | 2020 | 17 | 0.050 |
Why?
| | Microtubules | 1 | 2022 | 239 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2022 | 1144 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 451 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2008 | 4841 | 0.040 |
Why?
| | Immunotherapy | 1 | 2022 | 491 | 0.040 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 79 | 0.040 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 31 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 563 | 0.040 |
Why?
| | Receptor, ErbB-2 | 1 | 2020 | 303 | 0.040 |
Why?
| | Barrett Esophagus | 1 | 2020 | 151 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2020 | 569 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2023 | 1730 | 0.030 |
Why?
| | Male | 1 | 2019 | 56694 | 0.030 |
Why?
| | Prospective Studies | 1 | 2020 | 6391 | 0.020 |
Why?
|
|
Joshi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|